183 related articles for article (PubMed ID: 38341408)
1. Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach.
Bayona C; Alza L; Ranđelović T; Sallán MC; Visa A; Cantí C; Ochoa I; Oliván S; Herreros J
Cell Death Dis; 2024 Feb; 15(2):127. PubMed ID: 38341408
[TBL] [Abstract][Full Text] [Related]
2. Tetralol derivative NNC-55-0396 induces glioblastoma cell death by activating IRE1α, JNK1 and calcium signaling.
Visa A; Alza L; Cantí C; Herreros J
Biomed Pharmacother; 2022 May; 149():112881. PubMed ID: 35367758
[TBL] [Abstract][Full Text] [Related]
3. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
Macharia LW; Muriithi W; Heming CP; Nyaga DK; Aran V; Mureithi MW; Ferrer VP; Pane A; Filho PN; Moura-Neto V
BMC Cancer; 2021 Nov; 21(1):1248. PubMed ID: 34798868
[TBL] [Abstract][Full Text] [Related]
4. The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions.
Wang P; Yan Q; Liao B; Zhao L; Xiong S; Wang J; Zou D; Pan J; Wu L; Deng Y; Wu N; Gong S
Cell Death Dis; 2020 Nov; 11(11):992. PubMed ID: 33208727
[TBL] [Abstract][Full Text] [Related]
5. T-Type Ca
Visa A; Sallán MC; Maiques O; Alza L; Talavera E; López-Ortega R; Santacana M; Herreros J; Cantí C
Cancer Res; 2019 Apr; 79(8):1857-1868. PubMed ID: 30755443
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
[TBL] [Abstract][Full Text] [Related]
7. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
[TBL] [Abstract][Full Text] [Related]
8. NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction.
Kim KH; Kim D; Park JY; Jung HJ; Cho YH; Kim HK; Han J; Choi KY; Kwon HJ
J Mol Med (Berl); 2015 May; 93(5):499-509. PubMed ID: 25471482
[TBL] [Abstract][Full Text] [Related]
9. BK channels blockage inhibits hypoxia-induced migration and chemoresistance to cisplatin in human glioblastoma cells.
Rosa P; Catacuzzeno L; Sforna L; Mangino G; Carlomagno S; Mincione G; Petrozza V; Ragona G; Franciolini F; Calogero A
J Cell Physiol; 2018 Sep; 233(9):6866-6877. PubMed ID: 29319175
[TBL] [Abstract][Full Text] [Related]
10. Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models.
Park JH; Kim MJ; Kim WJ; Kwon KD; Ha KT; Choi BT; Lee SY; Shin HK
Cancer Lett; 2020 May; 478():71-81. PubMed ID: 32173479
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic and Reoxygenated Microenvironment: Stemness and Differentiation State in Glioblastoma.
Gaelzer MM; Santos MSD; Coelho BP; de Quadros AH; Simão F; Usach V; Guma FCR; Setton-Avruj P; Lenz G; Salbego CG
Mol Neurobiol; 2017 Oct; 54(8):6261-6272. PubMed ID: 27714633
[TBL] [Abstract][Full Text] [Related]
12. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA sequencing identifies critical transcription factors of tumor cell invasion induced by hypoxia microenvironment in glioblastoma.
Zhang Y; Zhang B; Lv C; Zhang N; Xing K; Wang Z; Lv R; Yu M; Xu C; Wang Y
Theranostics; 2023; 13(11):3744-3760. PubMed ID: 37441593
[No Abstract] [Full Text] [Related]
14. Estrogen receptor variant ER-α36 promotes tamoxifen agonist activity in glioblastoma cells.
Qu C; Ma J; Zhang Y; Han C; Huang L; Shen L; Li H; Wang X; Liu J; Zou W
Cancer Sci; 2019 Jan; 110(1):221-234. PubMed ID: 30417588
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
[TBL] [Abstract][Full Text] [Related]
17. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
[TBL] [Abstract][Full Text] [Related]
18. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
[TBL] [Abstract][Full Text] [Related]
19.
Shi Y; Jiang J; Cui Y; Chen Y; Dong T; An H; Liu P
DNA Cell Biol; 2021 Jan; 40(1):93-100. PubMed ID: 33181035
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.
Bar EE; Lin A; Mahairaki V; Matsui W; Eberhart CG
Am J Pathol; 2010 Sep; 177(3):1491-502. PubMed ID: 20671264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
